# Phase 1 Safety and Pharmacokinetics Study of Single Ascending Doses of BTA-C585 in Healthy Volunteers

> **NCT02558413** · PHASE1 · COMPLETED · sponsor: **Biota Pharmaceuticals, Inc.** · enrollment: 60 (actual)

## Conditions studied

- Pharmacokinetics
- Healthy Volunteers

## Interventions

- **DRUG:** BTA-C585 oral capsules
- **DRUG:** BTA-C585 matching placebo

## Key facts

- **NCT ID:** NCT02558413
- **Lead sponsor:** Biota Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2018-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02558413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02558413, "Phase 1 Safety and Pharmacokinetics Study of Single Ascending Doses of BTA-C585 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT02558413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*